CN101423633A - Thermoplastic elastomer composite material - Google Patents

Thermoplastic elastomer composite material Download PDF

Info

Publication number
CN101423633A
CN101423633A CNA2007101130977A CN200710113097A CN101423633A CN 101423633 A CN101423633 A CN 101423633A CN A2007101130977 A CNA2007101130977 A CN A2007101130977A CN 200710113097 A CN200710113097 A CN 200710113097A CN 101423633 A CN101423633 A CN 101423633A
Authority
CN
China
Prior art keywords
thermoplastic elastomer
tpe
sbc
tpu
tpo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101130977A
Other languages
Chinese (zh)
Inventor
殷敬华
李忠志
邵鹏君
杨志华
朱雪真
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEIGAO INNOVATION CO Ltd WEIHAI
Original Assignee
WEIGAO INNOVATION CO Ltd WEIHAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEIGAO INNOVATION CO Ltd WEIHAI filed Critical WEIGAO INNOVATION CO Ltd WEIHAI
Priority to CNA2007101130977A priority Critical patent/CN101423633A/en
Publication of CN101423633A publication Critical patent/CN101423633A/en
Pending legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

The invention relates to a thermoplastic elastomer (TPE) composite material, which consists of a polyolefin thermoplastic elastomer (TPO), a styrene thermoplastic elastomer (SBC) and a polyurethane thermoplastic elastomer (TPU), wherein each 100 weight portions of the thermoplastic elastomer (TPE) comprise 30 to 70 portions of the polyolefin thermoplastic elastomer (TPO), 1 to 50 portions of the styrene thermoplastic elastomer (SBC) and 1 to 50 portions of the polyurethane thermoplastic elastomer (TPU). The material has stable chemical properties, is difficult to decompose after being processed, has no smog, and does not pollute the environment due to production of carbon dioxide after burning treatment; and a transfusion system manufactured does not need to be added with low molecular compounds such as a stabilizer, a lubricant and pigment. The thermoplastic elastomer (TPE) composite material has a reasonable formula, stable performance and good flexibility, elasticity and toughness, does not pollute the environment when being destroyed, and is a special material which can be used for mass production of portable thermoplastic elastomer transfusion systems in a cleaning shop.

Description

A kind of thermoplastic elastomer composite material
Technical field
The present invention relates to a kind of macromolecular material, specifically a kind of improved thermoplastic elastomer (TPE) matrix material.It is exclusively used in makes disposable use thermoplastic elastomer (TPE) transfusion device.
Background technology
We know that transfusion device is big, the wide Dispoable medical utensil of a kind of consumption, and national annual consumption reaches more than 50 hundred million.The quality of transfusion device quality and safety in utilization are directly connected to everyone healthy.At present, disposable medical instrument both domestic and external generally uses PVC to be raw material.The PVC material has advantages such as comprehensive physicals is good, price is low, production technique is simple.Yet but a large amount of chemical additives and material itself are also residual a carcinogenic substance because the PVC material has added in the course of processing, and the PVC transfusion device contains micro-vinylchlorid compound, and this compound is had carinogenicity by internationally recognized to human body; Addition reaches 30% DEHP and is proved a kind of carcinogenic substance by experiment by " Nat'l Pharmaceutical ﹠ Biological Products Control Institute medicine equipment quality supervision and test center " in the PVC transfusion device, and human body is had potential hazardness; The PVC material has polarity, and some medicines especially antitumor drug are had adsorptivity, lessens the curative effect, and has improved the treatment cost.And chemical reaction easily takes place with individual drug, jeopardize patient's life security.The PVC transfusion device causes corrosion adding the hydrogenchloride and the poisonous smog that can decompose the generation trace man-hour to processing units, simultaneously operator's health is also brought threat; Depleted polyvinyl chloride burn processing is difficulty relatively, and bury can cause severe contamination to soil, burns can produce hydrogenchloride with dioxin gas, and it is carcinogenic substance that hydrogenchloride can form acid rain , dioxin gas.
Because there is above defective in the PVC material, the PVC material also is tending towards superseded gradually at the disposable medical product scope.Developed countries such as Europe, the U.S. and Japan are developing the substitute material of polyvinyl chloride, and the European Community has made the consumption that regulation is subdued polyvinyl chloride every year, and the amplitude of subduing reaches 17%.China has eliminated PVC infusion bag prevalent at the time in the mid-90.At present, manufacture the effort target that disposable infusion set becomes domestic and international manufacturer and exploitation mechanism with degradation material.Degradation material includes poly(lactic acid) macromolecular material, carbon dioxide polymer etc.Poly(lactic acid) is important lactic acid derivatives product, is to be the new bio degradable polymer material of monomer through chemosynthesis with lactic acid, and its nontoxic, nonirritant has good biocompatibility, biodegradable, absorption.Poly(lactic acid) is decomposed through enzyme in vivo, final carbonic acid gas and the water of forming, free from environmental pollution, thereby be considered to the most rising Biodegradable Polymers, but matter is hard because poly(lactic acid) has, fragility, shock strength are poor, at room temperature during prolonged preservation, the shortcoming that rerum natura can reduce and its purposes is suffered restraints.Carbon dioxide polymer has complete biodegradable, high obstructing performance.Utilize it to solve the concern that " white pollution " problem is subjected to various countries, and, have biocompatibility and therefore on medical material, have a wide range of applications because it has no side effect.But because also there are defective in its mechanical property and physicals aspect.
Summary of the invention
Technical problem to be solved by this invention is to overcome above-mentioned the deficiencies in the prior art, provide a kind of prescription rationally, stable performance, flexibility, elasticity, good toughness, free from environmental pollution during destruction, be specifically designed to thermoplastic elastomer (TPE) matrix material of producing disposable infusion set.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of thermoplastic elastomer (TPE) matrix material, it is characterized in that: it is made up of polyolefins thermoplastic elastomer (TPO), styrene analog thermoplastic elastomer (SBC), polyurethanes thermoplastic elastomer (TPU), contains 30-70 parts of polyolefins thermoplastic elastomers (TPO), 1-50 parts of styrene analog thermoplastic elastomers (SBC), 1-50 parts of polyurethanes thermoplastic elastomers (TPU) in per 100 weight part thermoplastic elastomers (TPE).
The present invention selects polyolefins thermoplastic elastomer (TPO), styrene analog thermoplastic elastomer (SBC), the polyurethanes thermoplastic elastomer (TPU) of proper ratio for use, has improved intensity, modulus and the rebound resilience of matrix material (TPE) effectively.
The present invention is with the main body plastics of thermoplastic elastomer (TPE) as disposable use thermoplastic elastomer (TPE) transfusion device PP Pipe Compound.Thermoplastic elastomer (TPE) material can be equal to PVC on a full physical and mechanical properties and price, and many key technical problems of aspects such as mould, frock and complete processing have been solved, can successfully this material be used to prepare disposable infusion set, solve the pollution problem of plastic waste.The advantage of the disposable use thermoplastic elastomer of the present invention (TPE) transfusion device PP Pipe Compound is that this material is a thermoplastic elastomer, does not wherein have vinyl chloride, so there is not any carcinogenic substance; This material itself has elasticity, so the transfusion device of making need not to add softening agent (DEHP), its harm does not exist in the TPE transfusion device; This material itself belongs to polyolefins, and chemical property is stable, and processing is difficult for decomposing, non smoke, and burning disposal produces carbonic acid gas, and is free from environmental pollution; The transfusion device of making need not to add micromolecular compounds such as stablizer, lubricant, pigment; This material is the manufacturing of nonpolarity polyolefin elastomer material, has good biological chemistry inertia, and medicine is not had absorption, reactionless, has guaranteed the security and the result of treatment of medication.The present invention fills a prescription rationally, stable performance, flexibility, elasticity, good toughness, and is free from environmental pollution during destruction, is the PP Pipe Compound that can produce disposable use thermoplastic elastomer (TPE) transfusion device in the cleaning shop in enormous quantities.
Embodiment
The invention will be further described below in conjunction with embodiment:
Thermoplastic elastomer of the present invention (TPE) matrix material, it is made up of polyolefins thermoplastic elastomer (TPO), styrene analog thermoplastic elastomer (SBC), polyurethanes thermoplastic elastomer (TPU), contains 30-70 parts of polyolefins thermoplastic elastomers (TPO), 1-50 parts of styrene analog thermoplastic elastomers (SBC), 1-50 parts of polyurethanes thermoplastic elastomers (TPU) in the prescription in per 100 weight part thermoplastic elastomers (TPE).
The compositing formula of each specific embodiment and performance of composites index are listed table 1 in:
Table 1
Embodiment 1 Embodiment 2 Embodiment 3 Embodiment 4 Embodiment 5 Embodiment 6
TPO 70 60 50 40 30 40
SBC 20 20 30 40 50 1
TPU 1 20 20 20 20 50
Shore hardness H A 80 88 79 92 95 86
Melt flow rate (MFR) (g/10min) 3.1 14 2.6 13 13.8 7.8
Elongation at break % 456 378 432 367 385 401
Tensile strength (MPa) 13.6 13.2 11 12.9 12 11.8
As can be seen from Table 1, all embodiment obtains comparatively ideal shore hardness, tensile strength and elongation at break.Material of the present invention is by polyolefins thermoplastic elastomer (TPO), styrene analog thermoplastic elastomer (SBC), polyurethanes thermoplastic elastomer (TPU) compound composition, this material can be equal to PVC on a full physical and mechanical properties and price, and many key technical problems of aspects such as mould, frock and complete processing have been solved, successful is used to prepare disposable infusion set with this material, has solved the pollution problem of plastic waste.
The embodiment of the invention 2 is compared with embodiment 1, and the melt flow rate (MFR) of gained plastics is higher.Embodiment 1 can be with the conduit material of disposable use TPE transfusion device, and embodiment 2 can be used as disposable use TPE infusion unit titrimeter material.Embodiment 4 compares with embodiment 3, and styrene analog thermoplastic elastomer (SBC) consumption increases, and hardness improves, and flow rate increases, and embodiment 4 can be used as the dropping funnel material.Embodiment 5 compares with embodiment 6, and better mobile, hardness is higher, also can be used as the dropping funnel material.
The various embodiments of the present invention various raw materials of filling a prescription mix, and granulation in the double-screw extruding pelletizing machine then can directly be carried out injection moulding on the injection moulding machine in 100,000 grades of cleaning shops like this, obtains goods.The resulting product color and luster is even, and outward appearance is good.
It is done chemical property and biological property detection, all meet company standard " disposable use TPE transfusion device " regulation, the result is shown in table 2 and table 3.
Table 2
Interventions Requested Assay
Potential of hydrogen 0.2
Barium, tin, copper, chromium, lead content Do not detect
Reducing substance 0.1
Non-volatile matter mg 0.1
Table 3
Interventions Requested Assay
Acute general toxicity There is not acute general toxic reaction
Pyrogen The pyrogen-free reaction
Haemolysis Hemolysis rate: 0.2%
Intracutaneous stimulates No intracutaneous stimulates
Cytotoxicity Cell-cytotoxic reaction: 0 grade
Sensitization of skin No sensitization of skin reaction
Genetoxic Hereditary-less toxicity
The disposable use thermoplastic elastomer of the present invention (TPE) transfusion device composite material special is a thermoplastic elastomer, does not wherein have vinyl chloride, so there is not any carcinogenic substance; This material itself has elasticity, and the transfusion device of manufacturing need not to add softening agent (DEHP), its harm does not exist in the TPE transfusion device; It is stable that this material itself belongs to the polyolefins chemical property, and processing is difficult for decomposing, non smoke, and burning disposal produces carbonic acid gas, and is free from environmental pollution; The transfusion device of making need not to add micromolecular compounds such as stablizer, lubricant, pigment; This material is the manufacturing of nonpolarity polyolefin elastomer material, has good biological chemistry inertia, and medicine is not had absorption, reactionless, has guaranteed the security and the result of treatment of medication; The present invention fills a prescription rationally, stable performance, flexibility, elasticity, good toughness, and is free from environmental pollution during destruction, is the PP Pipe Compound that can produce disposable use thermoplastic elastomer (TPE) transfusion device in the cleaning shop in enormous quantities.

Claims (2)

1. a thermoplastic elastomer (TPE) matrix material, it is characterized in that: it is made up of polyolefins thermoplastic elastomer (TPO), styrene analog thermoplastic elastomer (SBC), polyurethanes thermoplastic elastomer (TPU), contains 30-70 parts of polyolefins thermoplastic elastomers (TPO), 1-50 parts of styrene analog thermoplastic elastomers (SBC), 1-50 parts of polyurethanes thermoplastic elastomers (TPU) in per 100 weight part thermoplastic elastomers (TPE).
2. thermoplastic elastomer according to claim 1 (TPE) matrix material is characterized in that: contain 50-70 parts of polyolefins thermoplastic elastomers (TPO), 20-50 parts of styrene analog thermoplastic elastomers (SBC), 20-50 parts of polyurethanes thermoplastic elastomers (TPU) in the raw material in per 100 weight part thermoplastic elastomers (TPE).
CNA2007101130977A 2007-11-03 2007-11-03 Thermoplastic elastomer composite material Pending CN101423633A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101130977A CN101423633A (en) 2007-11-03 2007-11-03 Thermoplastic elastomer composite material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101130977A CN101423633A (en) 2007-11-03 2007-11-03 Thermoplastic elastomer composite material

Publications (1)

Publication Number Publication Date
CN101423633A true CN101423633A (en) 2009-05-06

Family

ID=40614529

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101130977A Pending CN101423633A (en) 2007-11-03 2007-11-03 Thermoplastic elastomer composite material

Country Status (1)

Country Link
CN (1) CN101423633A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101921450A (en) * 2010-09-21 2010-12-22 威海威高血液净化制品有限公司 Thermoplastic elastomer modified material for blood purification and circulation circuit
CN102230248A (en) * 2011-06-13 2011-11-02 台州东海塑料品制造有限公司 TPE (Thermoplastic Elastomer) yarns for weaving TPE mesh
CN105254972A (en) * 2015-08-05 2016-01-20 江苏亚邦天龙医用新材料有限公司 Thermoplastic elastomer granule for medical infusion apparatus
CN105801956A (en) * 2016-03-24 2016-07-27 深圳市炫丽塑胶科技有限公司 Medical infusion tube TPE material and preparing method thereof
CN108003542A (en) * 2017-12-15 2018-05-08 深圳恒方大高分子材料科技有限公司 A kind of peristaltic pump polyolefin elastomer and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101921450A (en) * 2010-09-21 2010-12-22 威海威高血液净化制品有限公司 Thermoplastic elastomer modified material for blood purification and circulation circuit
CN102230248A (en) * 2011-06-13 2011-11-02 台州东海塑料品制造有限公司 TPE (Thermoplastic Elastomer) yarns for weaving TPE mesh
CN102230248B (en) * 2011-06-13 2013-04-24 台州东海塑料品制造有限公司 TPE (Thermoplastic Elastomer) yarns for weaving TPE mesh
CN105254972A (en) * 2015-08-05 2016-01-20 江苏亚邦天龙医用新材料有限公司 Thermoplastic elastomer granule for medical infusion apparatus
CN105801956A (en) * 2016-03-24 2016-07-27 深圳市炫丽塑胶科技有限公司 Medical infusion tube TPE material and preparing method thereof
CN108003542A (en) * 2017-12-15 2018-05-08 深圳恒方大高分子材料科技有限公司 A kind of peristaltic pump polyolefin elastomer and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101550257B (en) Thermoplastic elastomer composite material
CN102164620B (en) Medical device, medical material and methods for producing same
CN101376730A (en) Thermoplastic elastomer material, preparation thereof and method for manufacturing medicinal bottle stopper by using the same
Kumar et al. Blends and composites of polyhydroxyalkanoates (PHAs) and their applications
CN102186669B (en) Multilayer flexible tubing
CN101519527B (en) Medical degradable composite material
CN101423633A (en) Thermoplastic elastomer composite material
JP2018076501A (en) Method for producing polymer/biological element alloy
CN101921451B (en) Thermoplastic elastomer composite material
CN104817807A (en) Environment-friendly recyclable cross-linked TPE (thermoplastic elastomer) tourniquet and preparation method thereof
EP3372643B1 (en) Complex composition of styrene-based block copolymer and pbt resin
CN102731956A (en) Medical thermoplastic elastomer composite material and preparation method thereof
CN106700384A (en) TPE (thermoplastic elastomer) material for manufacturing refrigerator sealing rubber strips and preparation process of TPE material
CN101921450A (en) Thermoplastic elastomer modified material for blood purification and circulation circuit
CN104387678B (en) Medical thermoplastic elastomer composition and preparation method of medical tube thereof
CN101486818A (en) Thermoplastic elastomer materials
CN101831132B (en) Resin composition
CN101451011A (en) Polyolefin thermoplastic elastomer blending resin and preparation method thereof
CN108003547A (en) Medical TPE sealing materials of heat resistant type and preparation method thereof
CN101798426A (en) Modified polypropylene bottle cap material
CN110885528B (en) Medical tubing, compositions and methods for making the same
CN1923892B (en) Degradation type composite material
CN107805375A (en) Medical lactic acid composite material and the disposable syringe of preparation
CN101462389A (en) Polyolefin multi-layer co-extrusion infusion film and technique of preparing the same
CN107805373A (en) A kind of therapeutic medical lactic acid composite material and its disposable syringe of preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090506